Drugs with Coverage Limitations and New Drug Review header

Drugs with Coverage Limitations and New Drug Review

Please Note:

  • Date Review Completed and Conclusion columns are blank for those products currently undergoing review. Details will be updated as efficiently as possible following initial review.
  • Conclusions are based upon decisions made at the time reviews are completed; historical information is not updated. Product management is subject to change based on new clinical evidence, provider/public feedback, advisory committee recommendations, financial considerations, etc.
  • This contains approximately one year of New Drug details.
  • Advisory Meeting Month is the month this recommendation will be presented at the quarterly Drug Prior Authorization Committee (DPAC) and Drug Utilization Review (DUR) Board meetings. For meeting dates, please see the MO HealthNet Calendar of Events. Certain agents may also be discussed at the quarterly Rare Disease Advisory Council meeting immediately prior to their presentation at their designated DPAC/DUR meeting.

For more information on this process please view the New Drug Review Process or contact the MO HealthNet Pharmacy Program at MHD.PharmacyAdmin@dss.mo.gov(link sends email) or call 573-751-6963. 

Trade Name Generic Name Date Review Began Date Review Completed Conclusion Advisory Committee Month
TAUVID VIAL FLORTAUCIPIR F-18 07/24/2022 09/06/2022 Open Access December 2022 / January 2022
DYANAVEL XR 15 MG TABLET AMPHETAMINE 07/17/2022 08/30/2022 PDL Edit December 2022 / January 2022
DYANAVEL XR 5 MG TABLET AMPHETAMINE 07/17/2022 08/30/2022 PDL Edit December 2022 / January 2022
DYANAVEL XR 10 MG TABLET AMPHETAMINE 07/17/2022 09/06/2022 Clinical Edit December 2022 / January 2022
DYANAVEL XR 20 MG TABLET AMPHETAMINE 07/17/2022 08/30/2022 PDL Edit December 2022 / January 2022
QUVIVIQ 50 MG TABLET DARIDOREXANT HCL 07/03/2022 08/16/2022 PDL Product December 2022 / January 2022
ASPRUZYO SPRINKLE ER 1000 MG PKT RANOLAZINE 07/03/2022 08/30/2022 PDL Edit December 2022 / January 2022
QUVIVIQ 25 MG TABLET DARIDOREXANT HCL 07/03/2022 08/23/2022 PDL Edit December 2022 / January 2022
IBSRELA 50 MG TABLET TENAPANOR HCL 07/03/2022 08/16/2022 Clinical Edit December 2022 / January 2022
VTAMA 1% CREAM TAPINAROF 07/03/2022 08/16/2022 PDL Product December 2022 / January 2022
ASPRUZYO SPRINKLE ER 500 MG PKT RANOLAZINE 07/03/2022 08/16/2022 Clinical Edit December 2022 / January 2022
AMVUTTRA 25 MG/0.5 ML SYRINGE VUTRISIRAN SODIUM 06/26/2022 08/16/2022 PDL Product September 2022 / October 2022
SKYRIZI 600 MG/10 ML VIAL RISANKIZUMAB-RZAA 06/26/2022 08/11/2022 PDL Product September 2022 / October 2022
SKYRIZI 360 MG/2.4 ML ON-BODY RISANKIZUMAB-RZAA 06/26/2022 08/11/2022 Clinical Edit September 2022 / October 2022
OLUMIANT 4 MG TABLET BARICITINIB 06/19/2022 08/02/2022 PDL Edit September 2022 / October 2022